{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Putative class counsel in generic drug antitrust MDL can’t get a slice of the opt-out pie . . . At least not yet",
"url": "https://www.lexblog.com/2019/10/21/putative-class-counsel-in-generic-drug-antitrust-mdl-cant-get-a-slice-of-the-opt-out-pie-at-least-not-yet/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-CQBSFEJN",
"url": "https://www.lexblog.com/lib/CQBSFEJN/"
},
"datePublished": "2019-10-21T15:46:10-04:00",
"dateModified": "2022-10-03T05:19:23-04:00",
"author": {
"@type": "Person",
"name": "Porter Wright"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Porter Wright Morris & Arthur LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Antitrust Law Source",
"about": "Antitrust, Competition and Trade · Class Action & Mass Torts",
"sourceUrl": "https://www.antitrustlawsource.com/?p=1597",
"sourceStability": "may-move"
}